The role of extracellular vesicles in skeletal muscle wasting

Abstract

Skeletal muscle wasting is a complicated metabolic syndrome accompanied by multiple diseases ranging from cancer to metabolic disorders and infectious conditions. The loss of muscle mass significantly impairs muscle function, resulting in poor quality of life and high mortality of associated diseases. The fundamental cellular and molecular mechanisms inducing muscle wasting have been well established, and those related pathways can be activated by a variety of extracellular signals, including inflammatory cytokines and catabolic stimuli. As an emerging messenger of cell‐to‐cell communications, extracellular vesicles (EVs) also get involved in the progression of muscle wasting by transferring bioactive cargoes including various proteins and non‐coding RNAs to skeletal muscle. Like a double‐edged sword, EVs play either a pro‐wasting or anti‐wasting role in the progression of muscle wasting, highly dependent on their parental cells as well as the specific type of cargo they encapsulate. This review aims to illustrate the current knowledge about the biological function of EVs cargoes in skeletal muscle wasting. Additionally, the potential therapeutic implications of EVs in the diagnosis and treatment of skeletal muscle wasting are also discussed. Simultaneously, several outstanding questions are included to shed light on future research.

Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy

“…Study from the same research group further demonstrated that growth differentiation factor 15 (GDF-15) presented in CRC cells-derived exosomes could also directly induce apoptosis of myocytes via regulating Bcl-2/caspase-3 pathways [ 184 ]. Collectively, these studies suggested that cargoes in cancer cells-derived exosomes play important roles in development of cachexia and may act as valuable therapeutic targets in exploring novel treatment in the future [ 185 , 186 ].…”

Extracellular vesicles in cancer cachexia: deciphering pathogenic roles and exploring therapeutic horizons

“…Muscle wasting and atrophy are significant characteristics of CC [ 63 , 64 ]. Recent evidence indicates that EVs play a crucial role in the muscle wasting associated with CC [ 65 ]. Research has demonstrated that EVs originating from cancer cells directly influence skeletal muscle cells, leading to muscle wasting (Fig.…”

Exosomes in the pathogenesis and treatment of cancer-related cachexia

“…Cancer cell-derived exosomes may play important roles in the communication between cancer tissue and skeletal muscle (or adipose tissue). The nucleic acids, lipids, or proteins in these exosomes may contribute to the biological processes underlying cancer-related cachexia, including regulating lipidolysis and skeletal muscle atrophy [ 27 – 29 ]. Meanwhile, stem cell-derived exosomes have demonstrated therapeutic effects in improving skeletal muscle regeneration [ 30 , 31 ].…”